Aztreonam is a/an –
**Core Concept**
Aztreonam is a synthetic **monobactam antibiotic** that works by inhibiting bacterial cell wall synthesis. It is primarily used to treat infections caused by **Gram-negative bacteria**. Aztreonam's unique structure makes it resistant to **beta-lactamase** degradation.
**Why the Correct Answer is Right**
Aztreonam is a **monobactam** because of its distinct monocyclic beta-lactam ring, which distinguishes it from other beta-lactam antibiotics like penicillins and cephalosporins. This structure allows aztreonam to maintain its efficacy against bacteria that produce beta-lactamases. Aztreonam binds to **penicillin-binding proteins** (PBPs) in the bacterial cell wall, inhibiting cell wall synthesis and ultimately leading to bacterial cell lysis.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because aztreonam is not a **cephalosporin**, which has a different beta-lactam ring structure.
**Option B:** Incorrect because aztreonam is not a **carbapenem**, a class of broad-spectrum beta-lactam antibiotics with a different mechanism of action.
**Option D:** Incorrect because aztreonam is not an **aminoglycoside**, a class of antibiotics that works by inhibiting protein synthesis.
**Clinical Pearl / High-Yield Fact**
Aztreonam is often used in patients with **penicillin allergy** because it has a low cross-reactivity with other beta-lactam antibiotics, making it a safer option. Its narrow spectrum of activity, primarily against **Gram-negative bacteria**, makes it useful for targeted therapy.
**Correct Answer:** D. monobactam antibiotic